nodes	percent_of_prediction	percent_of_DWPC	metapath
Propantheline—Salivation—Irinotecan—lung cancer	0.0301	0.0312	CcSEcCtD
Propantheline—Dysphagia—Pemetrexed—lung cancer	0.0173	0.0179	CcSEcCtD
Propantheline—Dermatitis atopic—Gemcitabine—lung cancer	0.0153	0.0159	CcSEcCtD
Propantheline—Dermatitis atopic—Paclitaxel—lung cancer	0.0128	0.0133	CcSEcCtD
Propantheline—Vision blurred—Crizotinib—lung cancer	0.0124	0.0129	CcSEcCtD
Propantheline—Salivary hypersecretion—Irinotecan—lung cancer	0.0113	0.0117	CcSEcCtD
Propantheline—Dermatitis atopic—Docetaxel—lung cancer	0.0109	0.0113	CcSEcCtD
Propantheline—Flushing—Teniposide—lung cancer	0.0104	0.0108	CcSEcCtD
Propantheline—Dysphagia—Erlotinib—lung cancer	0.0103	0.0106	CcSEcCtD
Propantheline—Dry mouth—Gefitinib—lung cancer	0.00995	0.0103	CcSEcCtD
Propantheline—Anaphylactic shock—Pemetrexed—lung cancer	0.00982	0.0102	CcSEcCtD
Propantheline—Constipation—Crizotinib—lung cancer	0.00919	0.00953	CcSEcCtD
Propantheline—Dysphagia—Vinorelbine—lung cancer	0.00887	0.0092	CcSEcCtD
Propantheline—Constipation—Pemetrexed—lung cancer	0.00839	0.00871	CcSEcCtD
Propantheline—Constipation—Gefitinib—lung cancer	0.00834	0.00866	CcSEcCtD
Propantheline—Confusional state—Teniposide—lung cancer	0.00802	0.00832	CcSEcCtD
Propantheline—Urticaria—Pemetrexed—lung cancer	0.0078	0.00809	CcSEcCtD
Propantheline—Tachycardia—Teniposide—lung cancer	0.00776	0.00805	CcSEcCtD
Propantheline—Urticaria—Gefitinib—lung cancer	0.00775	0.00804	CcSEcCtD
Propantheline—Asthenia—Crizotinib—lung cancer	0.00771	0.008	CcSEcCtD
Propantheline—Abdominal distension—Irinotecan—lung cancer	0.00736	0.00764	CcSEcCtD
Propantheline—Hypersensitivity—Pemetrexed—lung cancer	0.00723	0.00751	CcSEcCtD
Propantheline—Hypersensitivity—Gefitinib—lung cancer	0.00719	0.00746	CcSEcCtD
Propantheline—Dizziness—Crizotinib—lung cancer	0.0071	0.00737	CcSEcCtD
Propantheline—Asthenia—Pemetrexed—lung cancer	0.00704	0.00731	CcSEcCtD
Propantheline—Asthenia—Gefitinib—lung cancer	0.007	0.00726	CcSEcCtD
Propantheline—Vomiting—Crizotinib—lung cancer	0.00683	0.00709	CcSEcCtD
Propantheline—Dermatitis atopic—Doxorubicin—lung cancer	0.00679	0.00705	CcSEcCtD
Propantheline—Rash—Crizotinib—lung cancer	0.00677	0.00703	CcSEcCtD
Propantheline—Dermatitis—Crizotinib—lung cancer	0.00677	0.00702	CcSEcCtD
Propantheline—Flushing—Vinorelbine—lung cancer	0.00659	0.00684	CcSEcCtD
Propantheline—Feeling abnormal—Teniposide—lung cancer	0.00655	0.0068	CcSEcCtD
Propantheline—Dizziness—Pemetrexed—lung cancer	0.00649	0.00674	CcSEcCtD
Propantheline—Nausea—Crizotinib—lung cancer	0.00638	0.00662	CcSEcCtD
Propantheline—Urticaria—Teniposide—lung cancer	0.00632	0.00656	CcSEcCtD
Propantheline—Vomiting—Pemetrexed—lung cancer	0.00624	0.00648	CcSEcCtD
Propantheline—Vomiting—Gefitinib—lung cancer	0.0062	0.00644	CcSEcCtD
Propantheline—Rash—Pemetrexed—lung cancer	0.00619	0.00642	CcSEcCtD
Propantheline—Dermatitis—Pemetrexed—lung cancer	0.00618	0.00642	CcSEcCtD
Propantheline—Rash—Gefitinib—lung cancer	0.00615	0.00638	CcSEcCtD
Propantheline—Dermatitis—Gefitinib—lung cancer	0.00614	0.00638	CcSEcCtD
Propantheline—Dysphagia—Etoposide—lung cancer	0.00608	0.00631	CcSEcCtD
Propantheline—Abdominal distension—Paclitaxel—lung cancer	0.006	0.00623	CcSEcCtD
Propantheline—Dysphagia—Paclitaxel—lung cancer	0.00596	0.00619	CcSEcCtD
Propantheline—Anaphylactic shock—Topotecan—lung cancer	0.00589	0.00612	CcSEcCtD
Propantheline—Hypersensitivity—Teniposide—lung cancer	0.00586	0.00608	CcSEcCtD
Propantheline—Nausea—Pemetrexed—lung cancer	0.00583	0.00605	CcSEcCtD
Propantheline—Nausea—Gefitinib—lung cancer	0.00579	0.00601	CcSEcCtD
Propantheline—Asthenia—Teniposide—lung cancer	0.0057	0.00592	CcSEcCtD
Propantheline—Palpitations—Vinorelbine—lung cancer	0.00546	0.00567	CcSEcCtD
Propantheline—Flushing—Irinotecan—lung cancer	0.00543	0.00564	CcSEcCtD
Propantheline—Insomnia—Erlotinib—lung cancer	0.00527	0.00547	CcSEcCtD
Propantheline—Constipation—Vinblastine—lung cancer	0.00519	0.00538	CcSEcCtD
Propantheline—Vomiting—Teniposide—lung cancer	0.00506	0.00525	CcSEcCtD
Propantheline—Dysphagia—Docetaxel—lung cancer	0.00505	0.00525	CcSEcCtD
Propantheline—Anaphylactic shock—Vinorelbine—lung cancer	0.00504	0.00523	CcSEcCtD
Propantheline—Constipation—Topotecan—lung cancer	0.00504	0.00523	CcSEcCtD
Propantheline—Rash—Teniposide—lung cancer	0.00501	0.0052	CcSEcCtD
Propantheline—Dermatitis—Teniposide—lung cancer	0.00501	0.0052	CcSEcCtD
Propantheline—Feeling abnormal—Vinblastine—lung cancer	0.005	0.00519	CcSEcCtD
Propantheline—Constipation—Erlotinib—lung cancer	0.00499	0.00518	CcSEcCtD
Propantheline—Headache—Teniposide—lung cancer	0.00498	0.00517	CcSEcCtD
Propantheline—Flushing—Cisplatin—lung cancer	0.00493	0.00512	CcSEcCtD
Propantheline—Tachycardia—Vinorelbine—lung cancer	0.00492	0.00511	CcSEcCtD
Propantheline—Salivary hypersecretion—Doxorubicin—lung cancer	0.00488	0.00507	CcSEcCtD
Propantheline—Feeling abnormal—Topotecan—lung cancer	0.00486	0.00504	CcSEcCtD
Propantheline—Nausea—Teniposide—lung cancer	0.00472	0.0049	CcSEcCtD
Propantheline—Urticaria—Topotecan—lung cancer	0.00468	0.00486	CcSEcCtD
Propantheline—Flushing—Etoposide—lung cancer	0.00452	0.00469	CcSEcCtD
Propantheline—Hypersensitivity—Vinblastine—lung cancer	0.00447	0.00464	CcSEcCtD
Propantheline—Flushing—Paclitaxel—lung cancer	0.00443	0.0046	CcSEcCtD
Propantheline—Vision blurred—Cisplatin—lung cancer	0.00436	0.00452	CcSEcCtD
Propantheline—Asthenia—Vinblastine—lung cancer	0.00435	0.00452	CcSEcCtD
Propantheline—Hypersensitivity—Topotecan—lung cancer	0.00434	0.00451	CcSEcCtD
Propantheline—Constipation—Vinorelbine—lung cancer	0.00431	0.00447	CcSEcCtD
Propantheline—Asthenia—Topotecan—lung cancer	0.00423	0.00439	CcSEcCtD
Propantheline—Confusional state—Irinotecan—lung cancer	0.00419	0.00435	CcSEcCtD
Propantheline—Asthenia—Erlotinib—lung cancer	0.00418	0.00434	CcSEcCtD
Propantheline—Anaphylactic shock—Irinotecan—lung cancer	0.00416	0.00432	CcSEcCtD
Propantheline—Feeling abnormal—Vinorelbine—lung cancer	0.00415	0.00431	CcSEcCtD
Propantheline—Tension—Paclitaxel—lung cancer	0.00408	0.00423	CcSEcCtD
Propantheline—Anaphylactic shock—Gemcitabine—lung cancer	0.00405	0.0042	CcSEcCtD
Propantheline—Nervousness—Paclitaxel—lung cancer	0.00404	0.00419	CcSEcCtD
Propantheline—Dizziness—Vinblastine—lung cancer	0.00401	0.00416	CcSEcCtD
Propantheline—Urticaria—Vinorelbine—lung cancer	0.00401	0.00416	CcSEcCtD
Propantheline—Vision blurred—Paclitaxel—lung cancer	0.00392	0.00406	CcSEcCtD
Propantheline—Dizziness—Topotecan—lung cancer	0.0039	0.00405	CcSEcCtD
Propantheline—Vomiting—Vinblastine—lung cancer	0.00386	0.004	CcSEcCtD
Propantheline—Dizziness—Erlotinib—lung cancer	0.00386	0.004	CcSEcCtD
Propantheline—Headache—Vinblastine—lung cancer	0.0038	0.00394	CcSEcCtD
Propantheline—Anaphylactic shock—Cisplatin—lung cancer	0.00378	0.00392	CcSEcCtD
Propantheline—Insomnia—Irinotecan—lung cancer	0.00376	0.0039	CcSEcCtD
Propantheline—Flushing—Docetaxel—lung cancer	0.00375	0.0039	CcSEcCtD
Propantheline—Vomiting—Topotecan—lung cancer	0.00375	0.00389	CcSEcCtD
Propantheline—Rash—Topotecan—lung cancer	0.00372	0.00386	CcSEcCtD
Propantheline—Hypersensitivity—Vinorelbine—lung cancer	0.00371	0.00386	CcSEcCtD
Propantheline—Dermatitis—Topotecan—lung cancer	0.00371	0.00385	CcSEcCtD
Propantheline—Vomiting—Erlotinib—lung cancer	0.00371	0.00385	CcSEcCtD
Propantheline—Somnolence—Irinotecan—lung cancer	0.0037	0.00384	CcSEcCtD
Propantheline—Headache—Topotecan—lung cancer	0.00369	0.00383	CcSEcCtD
Propantheline—Tachycardia—Cisplatin—lung cancer	0.00368	0.00382	CcSEcCtD
Propantheline—Rash—Erlotinib—lung cancer	0.00368	0.00382	CcSEcCtD
Propantheline—Dermatitis—Erlotinib—lung cancer	0.00367	0.00381	CcSEcCtD
Propantheline—Palpitations—Paclitaxel—lung cancer	0.00367	0.00381	CcSEcCtD
Propantheline—Insomnia—Gemcitabine—lung cancer	0.00366	0.0038	CcSEcCtD
Propantheline—Headache—Erlotinib—lung cancer	0.00365	0.00379	CcSEcCtD
Propantheline—Asthenia—Vinorelbine—lung cancer	0.00362	0.00375	CcSEcCtD
Propantheline—Nausea—Vinblastine—lung cancer	0.0036	0.00374	CcSEcCtD
Propantheline—Somnolence—Gemcitabine—lung cancer	0.0036	0.00374	CcSEcCtD
Propantheline—Constipation—Irinotecan—lung cancer	0.00356	0.00369	CcSEcCtD
Propantheline—Nausea—Topotecan—lung cancer	0.0035	0.00363	CcSEcCtD
Propantheline—Confusional state—Etoposide—lung cancer	0.00349	0.00362	CcSEcCtD
Propantheline—Constipation—Gemcitabine—lung cancer	0.00346	0.0036	CcSEcCtD
Propantheline—Nausea—Erlotinib—lung cancer	0.00346	0.00359	CcSEcCtD
Propantheline—Dry mouth—Paclitaxel—lung cancer	0.00346	0.00359	CcSEcCtD
Propantheline—Anaphylactic shock—Etoposide—lung cancer	0.00346	0.00359	CcSEcCtD
Propantheline—Feeling abnormal—Irinotecan—lung cancer	0.00343	0.00356	CcSEcCtD
Propantheline—Confusional state—Paclitaxel—lung cancer	0.00342	0.00355	CcSEcCtD
Propantheline—Anaphylactic shock—Paclitaxel—lung cancer	0.00339	0.00352	CcSEcCtD
Propantheline—Tachycardia—Etoposide—lung cancer	0.00338	0.0035	CcSEcCtD
Propantheline—Erectile dysfunction—Methotrexate—lung cancer	0.00336	0.00348	CcSEcCtD
Propantheline—Feeling abnormal—Gemcitabine—lung cancer	0.00334	0.00346	CcSEcCtD
Propantheline—Dizziness—Vinorelbine—lung cancer	0.00333	0.00346	CcSEcCtD
Propantheline—Tachycardia—Paclitaxel—lung cancer	0.00331	0.00344	CcSEcCtD
Propantheline—Drowsiness—Methotrexate—lung cancer	0.00325	0.00337	CcSEcCtD
Propantheline—Vomiting—Vinorelbine—lung cancer	0.00321	0.00333	CcSEcCtD
Propantheline—Rash—Vinorelbine—lung cancer	0.00318	0.0033	CcSEcCtD
Propantheline—Dermatitis—Vinorelbine—lung cancer	0.00318	0.0033	CcSEcCtD
Propantheline—Abdominal distension—Doxorubicin—lung cancer	0.00318	0.0033	CcSEcCtD
Propantheline—Headache—Vinorelbine—lung cancer	0.00316	0.00328	CcSEcCtD
Propantheline—Dysphagia—Doxorubicin—lung cancer	0.00315	0.00327	CcSEcCtD
Propantheline—Palpitations—Docetaxel—lung cancer	0.00311	0.00323	CcSEcCtD
Propantheline—Feeling abnormal—Cisplatin—lung cancer	0.00311	0.00323	CcSEcCtD
Propantheline—Somnolence—Etoposide—lung cancer	0.00307	0.00319	CcSEcCtD
Propantheline—Insomnia—Paclitaxel—lung cancer	0.00307	0.00318	CcSEcCtD
Propantheline—Hypersensitivity—Irinotecan—lung cancer	0.00306	0.00318	CcSEcCtD
Propantheline—Somnolence—Paclitaxel—lung cancer	0.00301	0.00313	CcSEcCtD
Propantheline—Nausea—Vinorelbine—lung cancer	0.00299	0.00311	CcSEcCtD
Propantheline—Asthenia—Irinotecan—lung cancer	0.00298	0.0031	CcSEcCtD
Propantheline—Constipation—Etoposide—lung cancer	0.00296	0.00307	CcSEcCtD
Propantheline—Dry mouth—Docetaxel—lung cancer	0.00293	0.00304	CcSEcCtD
Propantheline—Asthenia—Gemcitabine—lung cancer	0.00291	0.00302	CcSEcCtD
Propantheline—Constipation—Paclitaxel—lung cancer	0.0029	0.00301	CcSEcCtD
Propantheline—Confusional state—Docetaxel—lung cancer	0.0029	0.00301	CcSEcCtD
Propantheline—Anaphylactic shock—Docetaxel—lung cancer	0.00287	0.00298	CcSEcCtD
Propantheline—Feeling abnormal—Etoposide—lung cancer	0.00285	0.00296	CcSEcCtD
Propantheline—Drowsiness—Doxorubicin—lung cancer	0.00281	0.00292	CcSEcCtD
Propantheline—Tachycardia—Docetaxel—lung cancer	0.00281	0.00291	CcSEcCtD
Propantheline—Feeling abnormal—Paclitaxel—lung cancer	0.00279	0.0029	CcSEcCtD
Propantheline—Hypersensitivity—Cisplatin—lung cancer	0.00278	0.00289	CcSEcCtD
Propantheline—Dizziness—Irinotecan—lung cancer	0.00275	0.00285	CcSEcCtD
Propantheline—Urticaria—Etoposide—lung cancer	0.00275	0.00285	CcSEcCtD
Propantheline—Asthenia—Cisplatin—lung cancer	0.00271	0.00281	CcSEcCtD
Propantheline—Urticaria—Paclitaxel—lung cancer	0.00269	0.0028	CcSEcCtD
Propantheline—Vomiting—Irinotecan—lung cancer	0.00264	0.00274	CcSEcCtD
Propantheline—Rash—Irinotecan—lung cancer	0.00262	0.00272	CcSEcCtD
Propantheline—Dermatitis—Irinotecan—lung cancer	0.00262	0.00272	CcSEcCtD
Propantheline—Headache—Irinotecan—lung cancer	0.0026	0.0027	CcSEcCtD
Propantheline—Insomnia—Docetaxel—lung cancer	0.0026	0.0027	CcSEcCtD
Propantheline—Vomiting—Gemcitabine—lung cancer	0.00258	0.00267	CcSEcCtD
Propantheline—Somnolence—Docetaxel—lung cancer	0.00256	0.00265	CcSEcCtD
Propantheline—Rash—Gemcitabine—lung cancer	0.00255	0.00265	CcSEcCtD
Propantheline—Dermatitis—Gemcitabine—lung cancer	0.00255	0.00265	CcSEcCtD
Propantheline—Hypersensitivity—Etoposide—lung cancer	0.00255	0.00264	CcSEcCtD
Propantheline—Headache—Gemcitabine—lung cancer	0.00254	0.00263	CcSEcCtD
Propantheline—Hypersensitivity—Paclitaxel—lung cancer	0.0025	0.00259	CcSEcCtD
Propantheline—Asthenia—Etoposide—lung cancer	0.00248	0.00258	CcSEcCtD
Propantheline—Nausea—Irinotecan—lung cancer	0.00247	0.00256	CcSEcCtD
Propantheline—Constipation—Docetaxel—lung cancer	0.00246	0.00255	CcSEcCtD
Propantheline—Asthenia—Paclitaxel—lung cancer	0.00243	0.00253	CcSEcCtD
Propantheline—Nausea—Gemcitabine—lung cancer	0.00241	0.0025	CcSEcCtD
Propantheline—Vomiting—Cisplatin—lung cancer	0.0024	0.00249	CcSEcCtD
Propantheline—Vision blurred—Methotrexate—lung cancer	0.00239	0.00248	CcSEcCtD
Propantheline—Rash—Cisplatin—lung cancer	0.00238	0.00247	CcSEcCtD
Propantheline—Dermatitis—Cisplatin—lung cancer	0.00238	0.00247	CcSEcCtD
Propantheline—Feeling abnormal—Docetaxel—lung cancer	0.00237	0.00246	CcSEcCtD
Propantheline—Flushing—Doxorubicin—lung cancer	0.00234	0.00243	CcSEcCtD
Propantheline—Dizziness—Etoposide—lung cancer	0.00229	0.00237	CcSEcCtD
Propantheline—Dizziness—Paclitaxel—lung cancer	0.00224	0.00233	CcSEcCtD
Propantheline—Nausea—Cisplatin—lung cancer	0.00224	0.00233	CcSEcCtD
Propantheline—Vomiting—Etoposide—lung cancer	0.0022	0.00228	CcSEcCtD
Propantheline—Rash—Etoposide—lung cancer	0.00218	0.00226	CcSEcCtD
Propantheline—Dermatitis—Etoposide—lung cancer	0.00218	0.00226	CcSEcCtD
Propantheline—Headache—Etoposide—lung cancer	0.00217	0.00225	CcSEcCtD
Propantheline—Tension—Doxorubicin—lung cancer	0.00216	0.00224	CcSEcCtD
Propantheline—Vomiting—Paclitaxel—lung cancer	0.00216	0.00224	CcSEcCtD
Propantheline—Rash—Paclitaxel—lung cancer	0.00214	0.00222	CcSEcCtD
Propantheline—Dermatitis—Paclitaxel—lung cancer	0.00214	0.00222	CcSEcCtD
Propantheline—Nervousness—Doxorubicin—lung cancer	0.00213	0.00222	CcSEcCtD
Propantheline—Headache—Paclitaxel—lung cancer	0.00212	0.00221	CcSEcCtD
Propantheline—Hypersensitivity—Docetaxel—lung cancer	0.00212	0.0022	CcSEcCtD
Propantheline—Confusional state—Methotrexate—lung cancer	0.00209	0.00217	CcSEcCtD
Propantheline—Anaphylactic shock—Methotrexate—lung cancer	0.00207	0.00215	CcSEcCtD
Propantheline—Vision blurred—Doxorubicin—lung cancer	0.00207	0.00215	CcSEcCtD
Propantheline—Asthenia—Docetaxel—lung cancer	0.00206	0.00214	CcSEcCtD
Propantheline—Nausea—Etoposide—lung cancer	0.00205	0.00213	CcSEcCtD
Propantheline—Nausea—Paclitaxel—lung cancer	0.00201	0.00209	CcSEcCtD
Propantheline—Palpitations—Doxorubicin—lung cancer	0.00194	0.00202	CcSEcCtD
Propantheline—Dizziness—Docetaxel—lung cancer	0.0019	0.00197	CcSEcCtD
Propantheline—Insomnia—Methotrexate—lung cancer	0.00187	0.00194	CcSEcCtD
Propantheline—Somnolence—Methotrexate—lung cancer	0.00184	0.00191	CcSEcCtD
Propantheline—Dry mouth—Doxorubicin—lung cancer	0.00183	0.0019	CcSEcCtD
Propantheline—Vomiting—Docetaxel—lung cancer	0.00183	0.0019	CcSEcCtD
Propantheline—Rash—Docetaxel—lung cancer	0.00181	0.00188	CcSEcCtD
Propantheline—Dermatitis—Docetaxel—lung cancer	0.00181	0.00188	CcSEcCtD
Propantheline—Confusional state—Doxorubicin—lung cancer	0.00181	0.00188	CcSEcCtD
Propantheline—Headache—Docetaxel—lung cancer	0.0018	0.00187	CcSEcCtD
Propantheline—Anaphylactic shock—Doxorubicin—lung cancer	0.00179	0.00186	CcSEcCtD
Propantheline—Tachycardia—Doxorubicin—lung cancer	0.00175	0.00182	CcSEcCtD
Propantheline—Nausea—Docetaxel—lung cancer	0.00171	0.00177	CcSEcCtD
Propantheline—Feeling abnormal—Methotrexate—lung cancer	0.00171	0.00177	CcSEcCtD
Propantheline—Urticaria—Methotrexate—lung cancer	0.00165	0.00171	CcSEcCtD
Propantheline—Insomnia—Doxorubicin—lung cancer	0.00162	0.00168	CcSEcCtD
Propantheline—Somnolence—Doxorubicin—lung cancer	0.00159	0.00166	CcSEcCtD
Propantheline—Constipation—Doxorubicin—lung cancer	0.00153	0.00159	CcSEcCtD
Propantheline—Hypersensitivity—Methotrexate—lung cancer	0.00153	0.00158	CcSEcCtD
Propantheline—Asthenia—Methotrexate—lung cancer	0.00149	0.00154	CcSEcCtD
Propantheline—Feeling abnormal—Doxorubicin—lung cancer	0.00148	0.00153	CcSEcCtD
Propantheline—Urticaria—Doxorubicin—lung cancer	0.00143	0.00148	CcSEcCtD
Propantheline—Dizziness—Methotrexate—lung cancer	0.00137	0.00142	CcSEcCtD
Propantheline—Hypersensitivity—Doxorubicin—lung cancer	0.00132	0.00137	CcSEcCtD
Propantheline—Vomiting—Methotrexate—lung cancer	0.00132	0.00137	CcSEcCtD
Propantheline—Rash—Methotrexate—lung cancer	0.00131	0.00136	CcSEcCtD
Propantheline—Dermatitis—Methotrexate—lung cancer	0.0013	0.00135	CcSEcCtD
Propantheline—Headache—Methotrexate—lung cancer	0.0013	0.00135	CcSEcCtD
Propantheline—Asthenia—Doxorubicin—lung cancer	0.00129	0.00134	CcSEcCtD
Propantheline—Nausea—Methotrexate—lung cancer	0.00123	0.00128	CcSEcCtD
Propantheline—Dizziness—Doxorubicin—lung cancer	0.00119	0.00123	CcSEcCtD
Propantheline—Vomiting—Doxorubicin—lung cancer	0.00114	0.00118	CcSEcCtD
Propantheline—Rash—Doxorubicin—lung cancer	0.00113	0.00117	CcSEcCtD
Propantheline—Dermatitis—Doxorubicin—lung cancer	0.00113	0.00117	CcSEcCtD
Propantheline—Headache—Doxorubicin—lung cancer	0.00112	0.00117	CcSEcCtD
Propantheline—Nausea—Doxorubicin—lung cancer	0.00107	0.00111	CcSEcCtD
Propantheline—CHRM3—GPCR downstream signaling—PIK3CG—lung cancer	2.45e-05	0.000669	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—FLT1—lung cancer	2.45e-05	0.000669	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—NOTCH3—lung cancer	2.43e-05	0.000664	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—APP—lung cancer	2.43e-05	0.000664	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—PIK3CG—lung cancer	2.43e-05	0.000663	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—APP—lung cancer	2.42e-05	0.000662	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—NOTCH3—lung cancer	2.42e-05	0.000662	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—FGF9—lung cancer	2.41e-05	0.000658	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—FGF9—lung cancer	2.4e-05	0.000656	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—NOTCH3—lung cancer	2.4e-05	0.000655	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—APP—lung cancer	2.4e-05	0.000655	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—FGF9—lung cancer	2.38e-05	0.00065	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—POMC—lung cancer	2.34e-05	0.000639	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—POMC—lung cancer	2.33e-05	0.000637	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—POMC—lung cancer	2.31e-05	0.000631	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—GSTP1—lung cancer	2.3e-05	0.000629	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—JUNB—lung cancer	2.3e-05	0.000628	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—JUNB—lung cancer	2.29e-05	0.000626	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—JUNB—lung cancer	2.27e-05	0.00062	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—CAT—lung cancer	2.24e-05	0.000613	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—PIK3CG—lung cancer	2.23e-05	0.00061	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—PIK3CG—lung cancer	2.22e-05	0.000608	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—PIK3CG—lung cancer	2.2e-05	0.000602	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—ABCB1—lung cancer	2.18e-05	0.000596	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—PIK3CD—lung cancer	2.16e-05	0.00059	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—PIK3CD—lung cancer	2.15e-05	0.000589	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—TYMS—lung cancer	2.14e-05	0.000585	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—PIK3CD—lung cancer	2.13e-05	0.000583	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—POMC—lung cancer	2.12e-05	0.000581	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—POMC—lung cancer	2.12e-05	0.000579	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—GSTM1—lung cancer	2.12e-05	0.000578	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—POMC—lung cancer	2.1e-05	0.000573	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—STK11—lung cancer	2.09e-05	0.000571	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—STK11—lung cancer	2.08e-05	0.000569	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—IL6R—lung cancer	2.07e-05	0.000566	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—IL6R—lung cancer	2.07e-05	0.000565	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—STK11—lung cancer	2.06e-05	0.000563	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—IL6R—lung cancer	2.05e-05	0.000559	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—FOXO3—lung cancer	2.02e-05	0.000551	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—FOXO3—lung cancer	2.01e-05	0.000549	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—CYP1A1—lung cancer	2.01e-05	0.000548	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—ERCC2—lung cancer	1.99e-05	0.000544	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—FOXO3—lung cancer	1.99e-05	0.000544	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—MAP2K1—lung cancer	1.97e-05	0.00054	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—MAP2K1—lung cancer	1.97e-05	0.000538	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—PIK3CD—lung cancer	1.96e-05	0.000536	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—PIK3CD—lung cancer	1.96e-05	0.000534	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—MAP2K1—lung cancer	1.95e-05	0.000533	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—PIK3CD—lung cancer	1.94e-05	0.000529	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—AVP—lung cancer	1.89e-05	0.000516	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—PIK3CB—lung cancer	1.88e-05	0.000515	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—AVP—lung cancer	1.88e-05	0.000514	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—PIK3CB—lung cancer	1.88e-05	0.000513	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—AVP—lung cancer	1.86e-05	0.000509	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—PIK3CB—lung cancer	1.86e-05	0.000508	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—IGF1R—lung cancer	1.82e-05	0.000497	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—IGF1R—lung cancer	1.81e-05	0.000495	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—CXCL8—lung cancer	1.81e-05	0.000495	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—CXCL8—lung cancer	1.8e-05	0.000493	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—IGF1R—lung cancer	1.79e-05	0.00049	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—CXCL8—lung cancer	1.79e-05	0.000488	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—HES1—lung cancer	1.79e-05	0.000488	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—HES1—lung cancer	1.78e-05	0.000486	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—HES1—lung cancer	1.76e-05	0.000482	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—RAF1—lung cancer	1.75e-05	0.000479	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—RAF1—lung cancer	1.75e-05	0.000477	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—IL2—lung cancer	1.73e-05	0.000473	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—RAF1—lung cancer	1.73e-05	0.000473	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—IL2—lung cancer	1.72e-05	0.000471	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—APOA1—lung cancer	1.72e-05	0.00047	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—PIK3CB—lung cancer	1.71e-05	0.000467	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—IL2—lung cancer	1.71e-05	0.000467	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—PIK3CB—lung cancer	1.7e-05	0.000466	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—PIK3CB—lung cancer	1.69e-05	0.000461	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—CXCL8—lung cancer	1.64e-05	0.000449	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—CXCL8—lung cancer	1.64e-05	0.000448	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—ERBB3—lung cancer	1.63e-05	0.000446	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—ERBB3—lung cancer	1.63e-05	0.000445	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—CXCL8—lung cancer	1.62e-05	0.000443	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—ERBB3—lung cancer	1.61e-05	0.00044	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PIK3CG—lung cancer	1.57e-05	0.00043	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—IL2—lung cancer	1.57e-05	0.000429	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—IL2—lung cancer	1.57e-05	0.000428	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—TERT—lung cancer	1.56e-05	0.000428	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—TERT—lung cancer	1.56e-05	0.000426	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—IL2—lung cancer	1.55e-05	0.000424	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—TERT—lung cancer	1.54e-05	0.000422	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—FGFR1—lung cancer	1.52e-05	0.000415	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—FGFR1—lung cancer	1.51e-05	0.000414	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—FGFR1—lung cancer	1.5e-05	0.00041	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—HIF1A—lung cancer	1.5e-05	0.000409	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—POMC—lung cancer	1.5e-05	0.000409	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—HIF1A—lung cancer	1.49e-05	0.000408	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—HIF1A—lung cancer	1.48e-05	0.000404	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—CREBBP—lung cancer	1.46e-05	0.000398	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—APOA1—lung cancer	1.44e-05	0.000395	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—APOA1—lung cancer	1.44e-05	0.000393	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—KDR—lung cancer	1.43e-05	0.000391	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—KDR—lung cancer	1.43e-05	0.00039	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—APOA1—lung cancer	1.43e-05	0.00039	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—KDR—lung cancer	1.41e-05	0.000386	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PIK3CD—lung cancer	1.38e-05	0.000378	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—ALB—lung cancer	1.36e-05	0.000373	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—KIT—lung cancer	1.32e-05	0.00036	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PIK3CG—lung cancer	1.32e-05	0.00036	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—APC—lung cancer	1.32e-05	0.00036	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—NRAS—lung cancer	1.32e-05	0.00036	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—APC—lung cancer	1.31e-05	0.000359	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PIK3CG—lung cancer	1.31e-05	0.000359	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—KIT—lung cancer	1.31e-05	0.000359	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—NRAS—lung cancer	1.31e-05	0.000359	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—EGF—lung cancer	1.3e-05	0.000356	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—APC—lung cancer	1.3e-05	0.000356	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PIK3CG—lung cancer	1.3e-05	0.000356	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—KIT—lung cancer	1.3e-05	0.000356	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—NRAS—lung cancer	1.3e-05	0.000356	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—EGF—lung cancer	1.3e-05	0.000355	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—EGF—lung cancer	1.29e-05	0.000352	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—MAPK3—lung cancer	1.26e-05	0.000345	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—MAPK3—lung cancer	1.26e-05	0.000344	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—POMC—lung cancer	1.25e-05	0.000343	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—POMC—lung cancer	1.25e-05	0.000342	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—MAPK3—lung cancer	1.25e-05	0.000341	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—BRAF—lung cancer	1.24e-05	0.000339	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—POMC—lung cancer	1.24e-05	0.000339	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—BRAF—lung cancer	1.24e-05	0.000338	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—IL6R—lung cancer	1.22e-05	0.000335	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—BRAF—lung cancer	1.22e-05	0.000334	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CREBBP—lung cancer	1.22e-05	0.000334	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—IL6R—lung cancer	1.22e-05	0.000333	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CREBBP—lung cancer	1.22e-05	0.000333	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—IL6R—lung cancer	1.21e-05	0.00033	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CREBBP—lung cancer	1.21e-05	0.00033	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PIK3CB—lung cancer	1.2e-05	0.000329	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—EGFR—lung cancer	1.2e-05	0.000328	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—EGFR—lung cancer	1.2e-05	0.000327	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PTGS2—lung cancer	1.19e-05	0.000326	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—EGFR—lung cancer	1.19e-05	0.000324	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MAP2K1—lung cancer	1.17e-05	0.000319	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MAP2K1—lung cancer	1.16e-05	0.000318	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PIK3CD—lung cancer	1.16e-05	0.000317	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PIK3CD—lung cancer	1.16e-05	0.000316	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MAP2K1—lung cancer	1.15e-05	0.000315	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—PIK3CA—lung cancer	1.15e-05	0.000314	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—PIK3CA—lung cancer	1.14e-05	0.000313	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PIK3CD—lung cancer	1.14e-05	0.000313	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—KRAS—lung cancer	1.13e-05	0.00031	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—PIK3CA—lung cancer	1.13e-05	0.00031	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—KRAS—lung cancer	1.13e-05	0.000309	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—KRAS—lung cancer	1.12e-05	0.000306	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—PIK3CA—lung cancer	1.04e-05	0.000285	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PTEN—lung cancer	1.04e-05	0.000284	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—PIK3CA—lung cancer	1.04e-05	0.000284	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MDM2—lung cancer	1.04e-05	0.000284	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MDM2—lung cancer	1.03e-05	0.000283	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—RAF1—lung cancer	1.03e-05	0.000283	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—RAF1—lung cancer	1.03e-05	0.000282	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—PIK3CA—lung cancer	1.03e-05	0.000281	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MDM2—lung cancer	1.02e-05	0.00028	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—ERBB2—lung cancer	1.02e-05	0.00028	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—RAF1—lung cancer	1.02e-05	0.000279	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—ERBB2—lung cancer	1.02e-05	0.000279	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—ERBB2—lung cancer	1.01e-05	0.000276	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PIK3CB—lung cancer	1.01e-05	0.000276	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MTOR—lung cancer	1.01e-05	0.000276	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MTOR—lung cancer	1.01e-05	0.000275	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PIK3CB—lung cancer	1.01e-05	0.000275	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MTOR—lung cancer	9.97e-06	0.000273	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PIK3CB—lung cancer	9.97e-06	0.000273	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—EP300—lung cancer	9.92e-06	0.000271	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CXCL8—lung cancer	9.71e-06	0.000265	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CXCL8—lung cancer	9.68e-06	0.000264	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—HRAS—lung cancer	9.64e-06	0.000264	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—HRAS—lung cancer	9.61e-06	0.000263	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CXCL8—lung cancer	9.58e-06	0.000262	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—HRAS—lung cancer	9.52e-06	0.00026	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—AKT1—lung cancer	9.38e-06	0.000256	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—AKT1—lung cancer	9.35e-06	0.000255	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CASP3—lung cancer	9.29e-06	0.000254	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—IL2—lung cancer	9.28e-06	0.000254	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CASP3—lung cancer	9.26e-06	0.000253	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—AKT1—lung cancer	9.26e-06	0.000253	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—IL2—lung cancer	9.25e-06	0.000253	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—IL6—lung cancer	9.23e-06	0.000252	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—IL6—lung cancer	9.2e-06	0.000251	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CASP3—lung cancer	9.17e-06	0.000251	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—IL2—lung cancer	9.16e-06	0.00025	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—IL6—lung cancer	9.11e-06	0.000249	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CCND1—lung cancer	9.04e-06	0.000247	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—JUN—lung cancer	9.02e-06	0.000247	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CCND1—lung cancer	9.01e-06	0.000246	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—JUN—lung cancer	9e-06	0.000246	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CCND1—lung cancer	8.93e-06	0.000244	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—JUN—lung cancer	8.91e-06	0.000243	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MMP9—lung cancer	8.78e-06	0.00024	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MMP9—lung cancer	8.75e-06	0.000239	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CDKN1A—lung cancer	8.75e-06	0.000239	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PTEN—lung cancer	8.73e-06	0.000239	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CDKN1A—lung cancer	8.72e-06	0.000238	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PTEN—lung cancer	8.7e-06	0.000238	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MMP9—lung cancer	8.67e-06	0.000237	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CDKN1A—lung cancer	8.64e-06	0.000236	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PTEN—lung cancer	8.62e-06	0.000235	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—AKT1—lung cancer	8.52e-06	0.000233	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—AKT1—lung cancer	8.49e-06	0.000232	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—AKT1—lung cancer	8.41e-06	0.00023	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—EP300—lung cancer	8.32e-06	0.000228	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—EP300—lung cancer	8.3e-06	0.000227	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—EP300—lung cancer	8.22e-06	0.000225	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—SRC—lung cancer	8.09e-06	0.000221	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—SRC—lung cancer	8.07e-06	0.000221	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—SRC—lung cancer	7.99e-06	0.000218	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—VEGFA—lung cancer	7.88e-06	0.000215	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—VEGFA—lung cancer	7.86e-06	0.000215	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—STAT3—lung cancer	7.81e-06	0.000213	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—NRAS—lung cancer	7.79e-06	0.000213	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—VEGFA—lung cancer	7.78e-06	0.000213	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—STAT3—lung cancer	7.78e-06	0.000213	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—NRAS—lung cancer	7.76e-06	0.000212	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—STAT3—lung cancer	7.71e-06	0.000211	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—NRAS—lung cancer	7.69e-06	0.00021	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MAPK3—lung cancer	7.46e-06	0.000204	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MAPK3—lung cancer	7.43e-06	0.000203	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MAPK3—lung cancer	7.36e-06	0.000201	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PIK3CA—lung cancer	7.34e-06	0.000201	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MYC—lung cancer	7.25e-06	0.000198	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MYC—lung cancer	7.23e-06	0.000198	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MYC—lung cancer	7.16e-06	0.000196	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—EGFR—lung cancer	7.1e-06	0.000194	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—EGFR—lung cancer	7.07e-06	0.000193	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—EGFR—lung cancer	7e-06	0.000191	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—KRAS—lung cancer	6.7e-06	0.000183	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—KRAS—lung cancer	6.68e-06	0.000183	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—KRAS—lung cancer	6.62e-06	0.000181	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PIK3CA—lung cancer	6.16e-06	0.000168	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PIK3CA—lung cancer	6.14e-06	0.000168	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PIK3CA—lung cancer	6.08e-06	0.000166	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—AKT1—lung cancer	6e-06	0.000164	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—TP53—lung cancer	5.96e-06	0.000163	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—TP53—lung cancer	5.94e-06	0.000162	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—TP53—lung cancer	5.88e-06	0.000161	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—HRAS—lung cancer	5.7e-06	0.000156	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—HRAS—lung cancer	5.68e-06	0.000155	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—HRAS—lung cancer	5.62e-06	0.000154	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—IL6—lung cancer	5.45e-06	0.000149	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—IL6—lung cancer	5.44e-06	0.000149	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—IL6—lung cancer	5.38e-06	0.000147	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—AKT1—lung cancer	5.03e-06	0.000137	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—AKT1—lung cancer	5.01e-06	0.000137	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—AKT1—lung cancer	4.97e-06	0.000136	CbGpPWpGaD
